kabutan

SEIKAGAKU CORPORATION(4548) Summary

4548
TSE Prime
SEIKAGAKU CORPORATION
690
JPY
-2
(-0.29%)
Jan 29, 3:30 pm JST
4.51
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
27.9
PBR
0.52
Yield
4.35%
Margin Trading Ratio
16.63
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
690 JPY 4.50 USD
Previous Close Jan 28
692 JPY 4.53 USD
High Jan 29, 3:11 pm
694 JPY 4.53 USD
Low Jan 29, 9:01 am
682 JPY 4.45 USD
Volume
194,800
Trading Value
0.13B JPY 0.88M USD
VWAP
688.22 JPY 4.5 USD
Minimum Trading Value
69,000 JPY 451 USD
Market Cap
0.04T JPY 0.26B USD
Number of Trades
293
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
282
1-Year High Dec 2, 2025
1,012
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 104,700 1,544,500 14.75
Jan 16, 2026 97,200 1,549,200 15.94
Jan 9, 2026 87,000 1,550,100 17.82
Dec 26, 2025 82,300 1,622,900 19.72
Dec 19, 2025 76,600 1,580,000 20.63
Company Profile
SEIKAGAKU CORPORATION specializes in the development of products related to joint diseases. Its hyaluronic acid preparations are distributed through partnerships with Kaken Pharmaceutical and Santen Pharmaceutical.
Sector
Pharmaceuticals
SEIKAGAKU CORPORATION engages in the research, development, manufacturing, procurement, and sales of pharmaceuticals and LAL (Limulus Amebocyte Lysate) products, including endotoxin detection reagents. In its pharmaceutical business, the company focuses on joint function improving agents as its main product line, while also offering ophthalmic surgical aids and treatments for lumbar disc herniation. Additionally, the company manufactures pharmaceutical ingredients and provides contract manufacturing services for pharmaceuticals. In the LAL business, SEIKAGAKU CORPORATION offers endotoxin detection reagents and glucan measurement in vitro diagnostic products. The company has several subsidiaries both domestically and internationally, conducting pharmaceutical and medical device development in North America, as well as manufacturing and sales operations overseas.